Pascal BECACHE, CEO DIGITAL PHARMA LAB
The pharmaceutical companies concerned by Parkinson’s disease must as quickly as possible commit behind Djamchid Dalili, scientist and patient, and his startup Diampark which is exploring new therapeutic paths to unlock the perspective. Digital Pharma Lab fully encourages and promotes cooperation between Labs and Diampark.
Didier TRANCHIER, BUSINESS ANGEL
Diampark is an exceptional human adventure, Djamchid Dalili, affected by Parkinson’s, puts everything in his life, his energy and his hope in an entrepreneurial and scientific approach to find how to overcome Parkinson’s disease as quickly as possible thanks to the Digital… a beautiful challenge that I support without reserve.
Yohan ATTAL, CEO MYBRAIN TECHNOLOGIES
DiamPark is a large-scale project combining the best of artificial intelligence and neuroscience. Its success will profoundly change the management of Parkinson’s disease. myBrain Technologies is proud to be a partner in such a promising project!